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Objectives: The aims of the current study are to (1) report the frequency of specific
sleep disturbance symptoms in Mild Cognitive Impairment (MCI) and cognitive healthy
older persons; (2) examine whether overall poor sleep and specific sleep disturbance
symptoms are more common in persons with MCI compared to cognitive healthy older
controls and; (3) examine the association between sleep disturbances and performance
in general and specific cognitive domains in persons with MCI and separately in cognitive
healthy older persons.
Methods: Data were collected at the Fondazione Ospedale San Camillo Istituto
di Ricovero e Cura a Carattere Scientifico (IRCCS), Venice, Italy as part of the
European VPH-DARE@IT project. We included 69 persons with MCI (mean age 75.7;
SD = 7.7) and 72 sex-matched cognitively healthy controls (mean age 71.8; SD = 7.0).
Participants underwent extensive neuropsychological assessment and evaluation of
subjective sleep performance with the Sleep Continuity in Alzheimer’s Disease Scale
(SCADS).
Results: A fifth of MCI patients (21.7%, n = 15) had poor sleep compared to 15.3%
(n = 11) of cognitively healthy controls. MCI patients had a 3.2 higher odds of having
poor sleep compared to cognitively healthy controls after adjustment for age, education,
sex, and general cognitive functioning (Odds Ratio (OR)=3.2; 95% Confidence Interval
(CI)=1.1–9.2). Persons who reported waking up twice or more during the night had
higher odds of being MCI compared to those who never wake or wake only once
(OR = 2.6; 95% CI = 1.1–6.1). In MCI patients, poor sleep was associated with better
general cognitive functioning and short-term working memory, whereas in cognitive
healthy older persons poor sleep was associated with impairment in episodic memory
performance and executive functioning.
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Discussion: Our results confirm previous studies showing that sleep disturbances
are common in MCI, and this may be due to an ongoing neurodegenerative process
rather than a symptom of cognitive impairment. Future research with objective sleep
measurements are needed in MCI as well as interventions to improve sleep with the aim
of preventing cognitive decline.
Keywords: sleep, cognition, MCI, cognitive impairment, aging, waking, neuropsychological testing, memory
INTRODUCTION
Sleep health covers a variety of dimensions, with many diﬀerent
deﬁnitions in the literature that generally cover a range of aspects
including sleep satisfaction, timing, eﬃciency, and duration
(Buysse, 2014). Sleep disorders are common in aging and increase
with advancing age (Gadie et al., 2017). Research has shown that
poor sleep is related to poorer general cognitive functioning as
well as impairment in speciﬁc cognitive domains (Gadie et al.,
2017). A meta-analysis concluded that persons with symptoms of
insomnia show impairment in cognitive functioning in episodic
memory, working memory and executive functioning (Fortier-
Brochu et al., 2012). Interestingly, research also suggests that
a cumulative index of sleep problems, rather than speciﬁc
symptoms of poor sleep, is the biggest risk factor for poorer
cognitive performance (Gadie et al., 2017). However, evidence is
conﬂicting, with some studies reporting no association between
sleep disturbance and cognition (Mecca et al., 2018), and some
even reporting slightly better cognitive functioning in those with
sleep problems (Kyle et al., 2017).
In addition to concurrent cognitive impairment, sleep quality
has also been linked with subsequent cognitive decline over time
(Virta et al., 2013; Blackwell et al., 2014) and speciﬁc aging
disorders such as dementia. At least a quarter of Alzheimer’s
disease (AD) patients exhibit severe sleep dysfunction (Moran
et al., 2005). It is thought that sleep disorders start to occur
in the preclinical phases of AD, as they have been found to
predict incident dementia (Ju et al., 2013, 2014; Lim et al., 2013;
Sterniczuk et al., 2013; Diem et al., 2016). Poor sleep quality has
been found to be associated with Mild Cognitive Impairment
(MCI) (Dlugaj et al., 2014), which often represents a prodromal
phase of preclinical dementia. A third of MCI patients exhibit
nighttime behaviors (Di Iulio et al., 2010), and speciﬁc symptoms
have been objectively observed in these individuals, such as
waking after sleep onset (Naismith et al., 2014). However, results
are conﬂicting, with some studies reporting no link between sleep
disturbances and cognitive decline (Mecca et al., 2018).
The overall objective of the current study is to contribute
to this ongoing discussion and provide further data to examine
the role of sleep disturbances in normal aging and MCI. We
aimed to look in detail at diﬀerent speciﬁc symptoms of sleep
disturbances using the Sleep Continuity in Alzheimer’s Disease
Scale (SCADS) (Manni et al., 2013), which is a validated Italian
tool for the early identiﬁcation and longitudinal monitoring
of sleep disturbances in dementia. The speciﬁc aims of the
current study were to: (1) report the frequency of speciﬁc
sleep disturbance symptoms in MCI and cognitive healthy older
persons; (2) examine whether overall poor sleep and speciﬁc sleep
disturbance symptoms are more common in persons with MCI
compared to cognitively healthy older controls and; (3) examine
the association between sleep disturbances and performance in
general and speciﬁc cognitive domains in persons with MCI, and
separately in cognitive healthy older persons.
MATERIALS AND METHODS
Study Population
Data were collected at the Fondazione Ospedale San Camillo
Istituto di Ricovero e Cura a Carattere Scientiﬁco (IRCCS), Lido,
Venice, Italy as part of the European VPH-DARE@IT project1.
The study was approved by the joint ethics committee of the
Health Authority Venice 12 and San Camillo IRCCS (Protocol
number 2014.08). All participants gave informed consent prior
to participation in the study.
MCI patients were recruited from the outpatient memory
service at the hospital. Eligible patients amongst consecutive
referrals to this service were enrolled if they met clinical criteria
for MCI (Petersen et al., 1999, 2001; Albert et al., 2011)
and met the following exclusion criteria: diagnostic entities of
clinical concern (brain tumor, hydrocephalous, lesions indicative
of multiple sclerosis, large cysts, and excessive leukoaraiosis),
chronic or acute cerebrovascular disease as main etiology,
history of transient ischemic attacks, presence of uncontrolled
brain seizures, peptic ulcer, cardiovascular disease, sick-sinus
syndrome, neuropathy with conduction diﬃculties, proof of
abnormal levels of folates, vitamin B12 or thyroid stimulating
hormone, signiﬁcant neuropsychiatric diagnoses such as Major
Depression, Anxiety or Psychosis, treatment with medication
for research purposes or with toxic eﬀects to internal organs
(e.g., drugs that could potentially be toxic to the liver or
heart, anti-epileptic drugs, or psychoactive medications such
as amphetamine or ketamine). Participants with signiﬁcant
disabilities or with MRI indication of a major diagnostic category
of non-neurodegenerative nature, which could otherwise explain
cognitive symptoms, were not considered for recruitment. Sleep
apnea and presence of neuropsychiatric sleep disturbances were
not used as exclusion criteria.
Healthy controls were recruited amongst carers and spouses
of the MCI patients and through word of mouth amongst
the residents of the island of Lido in Venice. The same
relevant exclusion criteria used for patients were also applied for
enrolment of controls.
1www.vph-dare.eu
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TABLE 1 | Characteristics of the study population.
Mild cognitive
impairment (MCI)
(n = 69)
Healthy controls
(n = 72)
All (n = 141)
Sex, female (n, %) n = 42 60.9% n = 42 58.3% n = 84 59.6%
Mean SD Mean SD Mean SD
Age 75.7 7.7 71.8 7.0 73.7 7.6
Years of education 9.6 3.8 12.5 4.2 11.1 4.3
Mini-mental state examination (MMSE) Range=19–30 25.6 2.9 28.6 1.4 27.1 2.7
Raven’s colored progressive matrices Range=9–36 23.3 6.0 29.7 4.1 26.6 6.0
Phonemic fluency Range=6 to 69 26.6 11.2 32.8 10.1 29.8 11.1
Semantic fluency Range=6 to 72 27.1 11.1 39.6 8.5 33.5 11.6
Attention matrices Range=17 to 60 42.6 9.2 52.0 6.3 47.4 9.2
Analogies Range=4 to 28 15.2 4.5 21.0 3.6 18.2 5.0
Token test Range=21 to 63 31.3 2.8 34.2 1.8 32.8 2.8
Rey figure – copy Range=3 to 336 25.8 8.5 33.7 2.8 29.8 7.4
Rey figure – delayed Range=0 to 326 6.2 4.9 14.7 5.6 10.5 6.8
Stroop – Time Range=0.5 to 119 39.2 22.6 23.3 9.4 31.1 18.9
Stroop – Error Range=−1 to 30 6.6 8.2 0.5 1.2 3.4 6.5
Digit span forward Range=4 to 8 5.3 0.9 6.0 1.0 5.7 1.0
Digit span backward Range=2 to 6 3.6 0.9 4.3 0.9 4.0 1.0
Corsi block test Range=2 to 8 4.4 0.9 5.0 1.1 4.7 1.1
Episodic memory – immediate Range=0 to 18 6.5 3.8 10.4 3.8 8.5 4.2
Episodic memory – delayed Range=0 to 24 6.8 5.2 14.5 4.5 10.7 6.2
Episodic memory – total Range=0 to 42 13.9 8.8 24.9 7.6 19.5 9.9
Word pairing test Range=0 to 20 8.0 4.3 11.5 3.7 9.8 4.3
Naming test Range=8 to 20 16.9 3.0 19.1 1.5 18.0 2.6
We included 141 persons aged ≥52 years (range 52–89);
69 persons with MCI and 72 sex-matched cognitively healthy
controls. Characteristics of the sample are reported in Table 1.
Neuropsychological Testing and MCI
Diagnosis
An extensive neuropsychological battery was administered to all
participants by a neuropsychologist, including Italian versions
of the Mini-Mental State Examination (MMSE) (Measso et al.,
1993), Raven’s colored progressive matrices (Basso et al., 1987),
Phonemic/Semantic ﬂuency tests (Novelli et al., 1986b), Digit
Cancelation test (Orsini et al., 1987), Similarity subtest from the
Wechsler Adult Intelligence Scale (Wechsler, 1981), Token test
(De Renzi and Faglioni, 1978), Rey complex ﬁgure test (Caﬀarra
et al., 2002a), Stroop test (Caﬀarra et al., 2002b), Corsi block test
(Orsini et al., 1987), immediate and delayed word recall (Novelli
et al., 1986a), Paired Associates (Novelli et al., 1986a), and the
Confrontation Naming test (Novelli et al., 1986b). Test scores
were corrected for age, education, and sex as necessary.
In addition to the neuropsychological testing, all participants
underwent a clinical examination by a neurologist. MCI was
diagnosed according to Petersen et al’s criteria (Petersen
et al., 1999, 2001; Albert et al., 2011). Diagnostic status
was reached by multidisciplinary consensus based on clinical,
neuropsychological and neuroimaging evidence, see Lassila et al.
(2018) for a description of the neuroimaging methods.
Sleep Continuity in Alzheimer’s Disease
Scale (SCADS)
Sleeping behaviors were assessed during clinical evaluation. We
used the SCADS scale (Manni et al., 2013, 2015), which has
been validated in Italian patients with cognitive impairment.
The scale includes nine self-reported questions regarding length
and quality of sleep, waking during the night, and diﬃculties in
getting to sleep; please see Figure 1 for all questions. For each
question participants rated the quality of sleep according to four
diﬀerent responses. For the current analyses all questions were
recoded so that score 1 indicates no problem and score 4 indicates
very poor. Individual questions as well as the total score were
investigated in the current analysis. This scale diﬀers from the
Neuropsychiatric Inventory because it assesses nine sleep-related
symptom separately, thus allowing a more comprehensive insight
into speciﬁc nighttime behaviors. However, it relies on self-report
from the patient rather than a caregiver.
Statistical Analysis
First, we reported sociodemographic variables (age, sex, and years
of education) and mean performance on the neuropsychological
tests in the whole population (n = 141), and separately in MCI
patients (n = 69) and cognitively healthy controls (n = 72).
Second, we calculated the mean scores on the 9 SCADS items.
Third, SCADS item scores were dichotomized into poor (score
of 3–4) vs. good/moderate (score 1–2), and we calculated the
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FIGURE 1 | Proportion of poor scores (>2) on each item of the Sleep Continuity in Alzheimer’s Disease Scale (SCADS) sleep scale in MCI and cognitively health
controls.
frequency of poor sleep in each of the nine items in MCI
patients and cognitively healthy controls. The nine scores were
then added to create an overall sleep performance score. Persons
scoring one standard deviation (SD) above the mean total
SCADS score were deﬁned as having poor sleep. Multivariate
logistic regression models with 95% CI were used to investigate
the association between (i) overall poor sleep and MCI status
and (ii) poor sleep on the individuals SCADS questions and
MCI status. Finally, we stratiﬁed the sample according to MCI
status to investigate the association between performance on the
individual neuropsychological tests and poor sleep (total SCADS
score).
RESULTS
The characteristics of the study population are shown in
Table 1; results are shown for the whole population, and
stratiﬁed according to MCI/control status. The mean age was
73.7 (SD = 7.6) years, with MCI patients being older than
cognitively healthy controls (t = 3.149; p = 0.002). There was
quite a high level of education in the sample (mean 11.1 years,
SD = 4.3), with MCI having a lower mean number of years of
education (t = −4.282; p = 0.000). As the sample was matched
for sex, the proportion of females was the same in MCI and
controls (60.9 vs. 58.3%). Mean scores on the MMSE and domain
speciﬁc tasks of cognitive functioning are also provided in the
Table.
Table 2 shows the mean score for each item of the SCADS
sleep scale for MCI, controls, and the whole population. Each
question ranges from 1 to 4, with a higher score indicating
poorer sleep. Figure 1 illustrates the percentage of person with
a poor score (3 or 4 out of 4) on each of the SCADS items,
stratiﬁed according to MCI status. Overall many people rated
their continuity of sleep as poor or very poor (75% of controls and
78.3% of MCI), and waking in the night was commonly reported
(questions 4 and 5) in both groups. Most people reported being
awake only 30 min or less during the night (question 5). Less than
a quarter of people reported having regular diﬃculties getting to
sleep (question 1).
Results of the 9 questions were summed to create a total
score (max 36 points), and a dichotomous variable was created
to indicate poor sleep. The mean total sleep score was 19.1.
(SD = 4.3). Persons scoring 1 SD above the mean were classiﬁed
as having poor sleep. A ﬁfth of MCI patients (21.7%, n = 15)
had poor sleep compared to 15.3% (n = 11) of cognitively
healthy controls. Table 3 shows the association between poor
sleep, demographic variables and MCI status. In the adjusted
OR, having MCI was associated with a 3.2 higher odds of having
poor sleep compared to cognitively healthy controls (adjusted
OR = 3.2; 95% CI = 1.1–9.2).
We investigated whether having a poor score (>2) on any
of the nine individual items on the SCADS scale was associated
with MCI. Only one question was associated with MCI. Almost
half of MCI patients woke up twice or more per night (n = 30,
43.5%) compared to a third of controls (n = 25, 24.7%). After
adjusting for sex, age, education, and MMSE question 4 (Do you
ever wake up during the night?) was associated with MCI status;
persons who reported waking up twice or more during the night
had a 2.6 higher odds of being MCI compared to those who
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TABLE 2 | Mean scores of the Sleep Continuity in Alzheimer’s Disease Scale (SCADS) sleep scale, in persons with MCI and cognitively healthy controls.
MCI (n = 69) Cognitively
healthy controls
(n = 72)
Total population
(n = 141)
Mean SD Mean SD Mean SD
Q1. Do you have difficulty getting to sleep? 1.7 1.0 1.9 1.0 1.8 1.0
Q2. How would you rate the overall quality of your sleep? 2.8 0.6 2.9 0.7 2.9 0.6
Q3. Do you wake up tired in the morning? 1.7 1.0 1.8 0.8 1.7 0.9
Q4. Do you ever wake up during the night? 2.5 0.9 2.4 0.9 2.5 0.9
Q5. How often, on average, do you wake up during the night in a week? 2.7 1.1 2.6 1.0 2.6 1.0
Q6. After waking in the night, are you able to get back to sleep again? 1.7 0.9 1.9 1.0 1.8 1.0
Q7. Do you tend to wake up too early in the morning? 1.9 0.9 2.0 0.9 1.9 0.9
Q8. How would you rate the overall continuity of your sleep? 2.1 0.6 2.2 0.7 2.2 0.6
Q9. Overall, how long are you awake during the night? 1.7 1.0 1.8 1.1 1.7 1.0
TABLE 3 | Logistic regression for the association between poor sleep (total
SCADS score), MCI status and sociodemographic factors.
Poor sleep (cutoff 23/36 total SCADS)
Crude Adjusted
Odds ratio (OR) (95% CI) OR∗ (95% CI)
MCI vs. controls 1.5 (0.7–3.6) 3.2 (1.1–9.2)
Sex (female) 2.7 (1.0–7.1) 2.7 (0.9–8.2)
Age 0.98 (0.9–1.04) 0.99 (0.94–1.1)
Education 1.1 (0.9–1.0) 1.1 (0.9–1.2)
MMSE 1.2 (0.9–1.4) 1.2 (0.99–1.6)
∗Adjusted for all variables in the model.
reported never waking or waking only once (adjusted OR = 2.6;
95% CI = 1.1–6.1).
Finally, we examined whether there was an association
between the total sleep score and performance on
neuropsychological tests (Table 4). Logistic regression models
adjusted for age, sex, and education were run separately in MCI
patients and cognitively healthy controls. In cognitively healthy
persons, poor sleep was signiﬁcantly associated with lower
performance on the Stroop test (Stroop Time OR = 1.12; 95%
CI = 1.04–1.26) and episodic memory total score (OR = 0.89;
95% CI = 0.79–1.00), and there was a borderline signiﬁcance
for episodic memory immediate (p = 0.093) and delayed recall
(p = 0.054). In contrast, in MCI patients, poor sleep scores were
associated with better cognitive performance on the MMSE
(OR = 1.42; 95% CI = 1.03–1.94) and the Corsi block test
(OR = 2.98; 95% CI = 1.14–7.76).
DISCUSSION
Our study demonstrated that persons with MCI are more than
three times more likely to have overall poor sleep than cognitive
healthy controls, even after adjustment for general cognitive
functioning. The speciﬁc symptom of waking during the night is
more common inMCI patients than controls. We also found that
overall self-reported sleep performance is diﬀerentially related
TABLE 4 | Association between total sleep score (higher score indicates worse
sleep) with neuropsychological tests, stratified by MCI/control status.
Healthy controls
(n = 72)
MCI (n = 69)
OR∗ (95%CI) OR∗ (95%CI)
MMSE 0.79 0.51–1.21 1.42 1.03–1.94
Raven’s progressive matrices 0.97 0.81–1.16 1.02 0.90–1.16
Phonemic fluency 0.98 0.92–1.06 1.02 0.96–1.09
Semantic fluency 0.96 0.87–1.06 1.01 0.95–1.07
Attention matrices 1.01 0.89–1.13 1.02 0.95–1.10
Analogies 0.56 1.07–1.31 1.04 0.89–1.22
Token test 1.82 0.94–3.53 1.33 0.93–1.91
Rey figure – copy 0.89 0.70–1.13 1.07 0.98–1.17
Rey figure – delayed 0.88 0.76–1.01 1.04 0.91–1.19
Stroop – Time 1.14 1.04–1.26 0.98 0.94–1.01
Stroop – Error 1.04 0.62–1.73 0.94 0.85–1.04
Digit span forward 0.92 0.43–1.95 1.09 0.48–2.44
Digit span backward 0.91 0.43–1.96 0.79 0.40–1.56
Corsi block test 0.92 0.48–1.74 2.98 1.14–7.76
Episodic memory – immediate 0.82 0.66–1.03 1.06 0.89–1.26
Episodic memory – delayed 0.84 0.69–1.03 1.11 0.98–1.27
Episodic memory – total 0.89 0.79–1.00 1.03 0.96–1.10
Word pairing test 0.94 0.78–1.14 1.12 0.96–1.30
Naming test 1.07 0.67–1.72 1.13 0.87–1.47
∗Adjusted OR calculated with logistic regression, with adjustment for age, sex, and
education.
to cognitive functioning in MCI and controls. In MCI patients,
persons with better general cognitive performance (MMSE) and
short-term working memory (Corsi block test) have poorer
sleep scores. In contrast, sleep disturbances are associated with
poorer episodic memory performance and executive functioning
in cognitive healthy controls.
Our results are in line with previous studies reporting an
association between poor sleep quality and MCI (Dlugaj et al.,
2014). Interestingly, the only symptom we found to speciﬁcally
be related to MCI was waking during the night, which supports
previous objective reports that sleep fragmentation occurs in
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the prodromal phases of AD, predicting subsequent dementia
(Lim et al., 2013). Further, results from a sleep laboratory
in which patients underwent overnight assessment with dim
light melatonin onset assessment showed that MCI patients had
greater wake after sleep onset, which was likely due to alterations
in the timing of melatonin secretion onset and amount (Naismith
et al., 2014). These results back the hypothesis that sleep disorders
are related to AD and already begin in the prodromal phase of
the disease (Ju et al., 2013, 2014; Lim et al., 2013; Sterniczuk et al.,
2013).
Much recent evidence has focused on establishing the
biological mechanisms through which sleep problems are related
to neurodegeneration and cognitive decline. One explanation
may be due to degeneration at the subcortical level. Degeneration
of the hypothalamus occurs in AD (Iacono and Sandyk, 1987;
Vercruysse et al., 2018), and this area is important for sleep
regulation (Ono and Yamanaka, 2017). There is also evidence of
a link between sleep disturbance and subcortical infarcts (Lim
et al., 2016). Sleep disturbances in AD are also inﬂuenced by
tau AD pathology (Holth et al., 2017), and there is also some
suggestion that hypothalamus dysfunctionmay be due to reduced
acetylcholine (Iacono and Sandyk, 1987).
There is a link between sleep disturbances and beta-amyloid
deposition as measured by PET (Spira et al., 2013) and it has
been proposed that the relationship may be bi-directional with
poor sleep contributing to amyloid deposition but also sleep
being disrupted as a result of amyloid plaque formation (Ju et al.,
2014). Mice studies have shown that neurotoxic waste products
such as beta-amyloid are cleared during sleep (Xie et al., 2013).
It has also been suggested that sleep and cognitive decline may
be related through stress and hormonal dysregulation (Maggio
et al., 2013). Further, circadian rhythms contribute to memory
formation possibly through molecular oscillator pathways such
as the cAMP signaling cascade, see Gerstner and Yin (2010) for a
review.
Our results showed that persons with MCI are more than
three times more likely to have sleep problems than cognitively
healthy controls even after adjustment for MMSE. This suggests
that the sleeping problems are not related to a drop in cognitive
functioning per se, but rather the sleep problems may reﬂect an
ongoing neurodegenerative process, themechanisms of which are
discussed above.
Interestingly, in our sample, poor sleep was associated
with better cognitive functioning in the MCI patients, in
terms of general cognitive functioning and short term working
memory. These results are somewhat surprising; although
there are previous studies that have reported that persons
with sleep problems such as insomnia have slightly better
cognitive functioning (Kyle et al., 2017). There are two potential
explanations for these results. First, as the SCADS is a self-rated
scale, it is possible that MCI patients with a higher MMSE score
are in a milder phase of the syndrome and are able to better
report their sleep performance with more accuracy. Second,
these milder MCI cases may be more aware of their prognosis
and experience stress and worry about an impending dementia,
which consequently aﬀects their sleep. Sleep quality is strongly
associated with both anxiety and depression (Gadie et al., 2017),
which are also common symptoms in MCI (Di Iulio et al.,
2010; Palmer et al., 2010). It is also worth noting that MCI is a
heterogeneous syndrome, which does not always progress to AD
and, thus, there may be other underlying etiologies that cause the
cognitive impairment but do not cause sleep disturbances.
Our study also found that in cognitively healthy participants
poor sleep was related to worse performance in episodic memory
and executive functioning, in agreement with previous ﬁndings
(Wilckens et al., 2014; Bernstein et al., 2018); low sleep eﬃciency
can lead to loss of attention, resulting in more errors on executive
tasks like the Stroop test. It has also been hypothesized that
stress hormones have a role in sleep disruption and cognition
during aging (Maggio et al., 2013). Another hypothesis is that
poor sleep is related to impaired cognitive functioning via a third
pathway, such as neuropsychiatric symptoms. Studies suggest
that night-time behaviors often cluster with other aﬀective
symptoms, particularly depression and anxiety, and that up to
two-thirds of non-demented persons with aﬀective syndromes
characterized by depression, anxiety and nighttime behaviors
take psychotropic medications (Cravello et al., 2011), which may
also aﬀect cognitive functioning. Unfortunately, in the current
study we were not able to investigate the potential confounding
eﬀect of prescription drugs or neuropsychiatric symptoms.
There are several strengths of our study. Both cases and
controls underwent the same rigorous evaluation for MCI
diagnosis and extensive neuropsychological assessment. We also
used a sleep scale that has been validated in an Italian population
and is designed to address sleep problems related to cognitive
decline and dementia. However, several limitations should also
be discussed. First, as the study is cross-sectional we cannot
determine any causal relationships between cognitive functioning
and sleep disturbances. Second, the sleep scale was self-reported
and we cannot exclude that a reporting bias may have occurred
due to cognitive impairment in the MCI patients. Further,
although diﬃcult to measure in a large sample, an objective
measure of sleep performance would provide more accurate
results. Third, although cases and controls were matched by sex,
and we made adjustments for sociodemographics, there may be
other unmeasured confounding that may aﬀect the relationships
investigated, particularly psychiatric factors such as depression
and anxiety or medication use. Another important limitation is
that we were not able to establish whether waking during the
night was due to obstructive sleep apnea, which is known to
cause cognitive deﬁcits and increase the risk ofMCI and dementia
(Gagnon et al., 2014). Finally, although statistically signiﬁcant,
the reported OR on the association between MCI and poor sleep
should be interpreted with caution due to the lower CI being close
to 1.
Our results support previous ﬁndings in the literature that
suggest that sleep problems are common in MCI, which may
be relevant for clinicians to consider during clinical evaluation.
There is much discussion about whether speciﬁc interventions
to improve sleep will help to prevent AD (Spira and Gottesman,
2017), but as there is no evidence that interventions will have a
successful preventative eﬀect and may be diﬃcult to implement
on a large scale, there are currently no guidelines regarding this
issue. Future research is needed, with specially designed clinical
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trials on pharmaceutical and non-pharmaceutical interventions
focused on diﬀerent outcomes, including prevention of AD but
also cognitive impairment in general in older adults. Considering
the potential side eﬀects of pharmaceutical drugs, lifestyle
interventions such as exercise and other non-pharmaceutical
interventions may be of particular interest. A recent review
concluded that there is insuﬃcient evidence on the role
of cognitive behavioral therapy for insomnia for improving
cognitive performance (Herbert et al., 2018). One issue in
the current literature is the wide range of sleep disorders
and symptoms and variation in deﬁning the problems, from
insomnia, sleep-disordered breathing, and ineﬃcient sleeping, to
delayed sleeping. Objective measures of sleep performance such
as actigraphy, bed sensors, and eyelid movement sensors (Van de
Water et al., 2011) are needed on a wider scale in MCI patients to
better understand the role of sleeping in this syndrome.
CONCLUSION
Our results show that sleep disturbances are impaired in MCI,
possibly due to ongoing neurodegenerative processes, and that
in cognitive healthy controls poor sleep is associated with poor
episodic memory and executive functioning.
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